Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
De Lisi V, Cocconi G, Angelini F, Cavicchi F, Di Costanzo F, Gilli G, Rodinò C, Soldani M, Tonato M, Finardi C. De Lisi V, et al. Among authors: di costanzo f. Cancer. 1996 Jan 15;77(2):245-50. doi: 10.1002/(SICI)1097-0142(19960115)77:2<245::AID-CNCR4>3.0.CO;2-L. Cancer. 1996. PMID: 8625230 Clinical Trial.
5-Fluorouracil versus a combination of BCNU, adriamycin, 5-FU and mitomycin C in advanced gastric cancer: a prospective randomized study of the Italian Clinical Research Oncology Group.
De Lisi V, Cocconi G, Tonato M, Di Costanzo F, Leonardi F, Soldani M. De Lisi V, et al. Among authors: di costanzo f. Recent Results Cancer Res. 1988;110:212-8. doi: 10.1007/978-3-642-83293-2_33. Recent Results Cancer Res. 1988. PMID: 3136519 Clinical Trial. No abstract available.
Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
Cocconi G, Bella M, Zironi S, Algeri R, Di Costanzo F, De Lisi V, Luppi G, Mazzocchi B, Rodinò C, Soldani M, et al. Cocconi G, et al. Among authors: di costanzo f. J Clin Oncol. 1994 Dec;12(12):2687-93. doi: 10.1200/JCO.1994.12.12.2687. J Clin Oncol. 1994. PMID: 7989945 Clinical Trial.
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC).
Boni C, Savoldi L, Bisagni G, Ceci G, Crinò L, De Lisi V, Di Costanzo F, Lasagni L, Manenti AL, Moretti G, Rondini E, Sassi M, Zadro A. Boni C, et al. Among authors: di costanzo f. Eur J Cancer. 1998 Nov;34(12):1974-6. doi: 10.1016/s0959-8049(98)00231-7. Eur J Cancer. 1998. PMID: 10023325 Clinical Trial.
Modulation of fluorouracil by methotrexate, leucovorin, and cisplatin (M-FLP) in the treatment of advanced pancreatic cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC).
Di Costanzo F, Canaletti R, Sdrobolini A, Olmeo N, Luppi G, Pucci F, Cavicchi F, Gasperoni S, Rodinò C, Zironi S, Angiona S, Contu A. Di Costanzo F, et al. Am J Clin Oncol. 2000 Jun;23(3):314-8. doi: 10.1097/00000421-200006000-00022. Am J Clin Oncol. 2000. PMID: 10857901 Clinical Trial.
Low-dose aminoglutethimide with and without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
Cocconi G, Bisagni G, Ceci G, Bacchi M, Boni C, Brugia M, Carpi A, Di Costanzo F, Franciosi V, Gori S, et al. Cocconi G, et al. Among authors: di costanzo f. J Clin Oncol. 1992 Jun;10(6):984-9. doi: 10.1200/JCO.1992.10.6.984. J Clin Oncol. 1992. PMID: 1588379 Clinical Trial.
191 results